Tested. Trusted. Better.Control-IQ+ Technology
Our Best Algorithm Ever
Tighter Control
Predicts glucose levels 30 minutes ahead and automatically adjusts or suspends insulin every five minutes.
The Only System with AutoBolus
Better A1c results, even for people who occasionally miss meal boluses.3
Better Time in Range Overnight
The only system with a dedicated Sleep Activity. Real-world data demonstrated a 90% overnight time in range.2
Immediate Improvements
Study participants saw a 13% time in range improvement within the first 24 hours.1
The world's smallest, durable AID system4 is now powered by Control‑IQ+ technology
The impressively small Tandem Mobi gives you more options for how to wear your insulin pump — so you can worry less about your diabetes.
A Tandem Diabetes Care Specialist will help you get started.
#1 Favorite Pump
You may be able to experience the life-changing benefits of Tandem automated insulin delivery for $0 out of pocket.
Seagrove PWD Survey: Nov. 2024.
Cost per day calculation reflects the average monthly out-of-pocket cost for pump and disposables necessary to utilize Tandem pump therapy over the life of the 48-month pump warranty. Assumes consumption of 10 infusion sets and cartridges per month.
$0 out of pocket claim based on direct orders from Tandem customers with commercial insurance from 1/1/2025-12/31/2025. Data on file. Actual cost may vary and is subject to individual insurance coverage.
Additional Features of Tandem Mobi
Inductive Charging
Holds 200 units of Insulin
Water-Resistant (IP28)*
CGM Sensors
The Tandem Mobi system currently integrates with Dexcom G6 and standard Dexcom G7 (10-Day) sensors.†
Infusion Sets
The system is compatible with all Tandem infusion sets, so you can choose the length, angle, and material that best fits your lifestyle.
Control-IQ+ also available with t:slim X2 pump
The t:slim X2 insulin pump is an all-in-one system that features a sleek and user-friendly color touchscreen and multiple CGM options.
* Tested at 8 feet for 2 hours.
† CGM sold separately.
References
Note: Studies were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 sensor.
1. Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
2. Breton MD, Kovatchev BP. Diabetes Technol Ther. 2021;23(9):601-608.
3. Akturk HK, et al. Diabetes Technology Meeting. October 12-17, 2024. Diabetes Sci Technol. 2024; In Press.
4. As of March, 2025. Data on file, Tandem Diabetes Care.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.